398 related articles for article (PubMed ID: 31808193)
1. Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study.
Crismale JF; Khalid M; Bhansali A; De Boccardo G; Khaim R; Florman SS; Shapiro R; Schiano TD
Clin Transplant; 2020 Jan; 34(1):e13761. PubMed ID: 31808193
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience.
Elbeshbeshy H; Modi N; Patel T; Matthews I; Kampert T; Lee J; Okeke R; Caliskan Y; Fleetwood V; Varma C; Gabris B; Bastani B; Abu Al Rub F; Guenette A; Befeler A; Agbim U; Desai R; Alsabbagh E; Qureshi K; Schnitzler M; Lentine KL; Randall HB; Nazzal M
Clin Transplant; 2024 Jan; 38(1):e15161. PubMed ID: 37842872
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
[TBL] [Abstract][Full Text] [Related]
4. Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors.
Terrault NA; Burton J; Ghobrial M; Verna E; Bayer J; Klein C; Victor D; Mohan S; Trotter J; Dodge J; Niemann CU; Rubin RA
Hepatology; 2021 Jun; 73(6):2110-2123. PubMed ID: 32926749
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care.
Bohorquez H; Bugeaud E; Bzowej N; Scheuermann J; Hand J; Bruce D; Carmody I; Cohen A; Joshi S; Seal J; Sonnier D; Therapondos G; Girgrah N; Anders S; Loss GE
Liver Transpl; 2021 Apr; 27(4):548-557. PubMed ID: 33098277
[TBL] [Abstract][Full Text] [Related]
6. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
[TBL] [Abstract][Full Text] [Related]
7. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C-positive donor to negative recipient kidney transplantation: A real-world experience.
Jandovitz N; Nair V; Grodstein E; Molmenti E; Fahmy A; Abate M; Bhaskaran M; Teperman L
Transpl Infect Dis; 2021 Jun; 23(3):e13540. PubMed ID: 33259125
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients.
Bari K; Luckett K; Kaiser T; Diwan T; Cuffy M; Schoech MR; Safdar K; Blackard JT; Apewokin S; Paterno F; Sherman KE; Zucker SD; Anwar N; Shah SA
Hepatology; 2018 May; 67(5):1673-1682. PubMed ID: 29205441
[TBL] [Abstract][Full Text] [Related]
10. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report.
Said A; Weiss M; Varhelyi A; Farago R; Ballweg C; Rice J; Agarwal P; Fernandez L; Foley D
Transpl Infect Dis; 2021 Apr; 23(2):e13466. PubMed ID: 32931616
[TBL] [Abstract][Full Text] [Related]
11. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
Bowring MG; Shaffer AA; Massie AB; Cameron A; Desai N; Sulkowski M; Garonzik-Wang J; Segev DL
Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors.
Kwong AJ; Wall A; Melcher M; Wang U; Ahmed A; Subramanian A; Kwo PY
Am J Transplant; 2019 May; 19(5):1380-1387. PubMed ID: 30378723
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
[TBL] [Abstract][Full Text] [Related]
14. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
[TBL] [Abstract][Full Text] [Related]
15. Access to direct-acting antivirals for hepatitis C-negative transplant recipients receiving organs from hepatitis C-viremic donors.
Bova S; Cameron A; Durand C; Katzianer J; LeGrand M; Boyer L; Glorioso J; Toman LP
Am J Health Syst Pharm; 2022 Jan; 79(3):173-178. PubMed ID: 33987658
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of hepatitis C virus seropositive donors to hepatitis C virus seronegative liver recipients: A large single center analysis.
Sobotka LA; Mumtaz K; Wellner MR; Kelly SG; Conteh LF; Hanje AJ; Schenk A; El-Hinnawi A; Black S; Washburn K; Pesavento T; Daloul R; Michaels AJ
Ann Hepatol; 2021; 24():100318. PubMed ID: 33515801
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes.
Molnar MZ; Azhar A; Tsujita M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Kothadia J; Agbim UA; Maliakkal B; Satapathy SK; Kovesdy CP; Nair S; Eason JD
Am J Kidney Dis; 2021 May; 77(5):739-747.e1. PubMed ID: 33333148
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of liver from hepatitis C-infected donors to hepatitis C RNA-negative recipients: Histological and virologic outcome.
Nair SP; Marella HK; Maliakkal B; Snyder H; Handley C; Kothadia JP; Ali B; Satapathy SK; Molnar MZ; Clark I; Jain R; Helmick R; Eymard C; Eason JD
Clin Transplant; 2021 May; 35(5):e14281. PubMed ID: 33690929
[TBL] [Abstract][Full Text] [Related]
19. Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
Czarnecka P; Czarnecka K; Tronina O; Baczkowska T; Durlik M
Ren Fail; 2022 Dec; 44(1):434-449. PubMed ID: 35260039
[TBL] [Abstract][Full Text] [Related]
20. Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients.
Friebus-Kardash J; Gäckler A; Kribben A; Witzke O; Wedemeyer H; Treckmann J; Herzer K; Eisenberger U
Transpl Infect Dis; 2019 Oct; 21(5):e13146. PubMed ID: 31306562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]